Tags
You are here: Home
APIs
Innovation Expected from API Manufacturers
Up To Task - Facing a huge patent cliff and a less-than-robust pipeline, pharma companies must look to customized and personalized medicines. This is where API manufacturers are expected to step up to the plate. For our API business, Asia is ... more20.07.2011Johnson Matthey Q1 Underlying Profit Rises; Sees Strong Growth In H1
Autocatalysts and precious metals maker Johnson Matthey reported Tuesday a strong growth in its first-quarter profit and sales, benefited principally from higher demand for products and operational leverage. Looking ahead, the company projects significant growth in the first half. In its interim management statement for the first quarter, Johnson Matthey noted that its underlying profit before tax increased 19% from last year to 98.2 million pounds. Sales for the quarter, excluding sales of precious metals, grew 12% to 617 million pounds. more
Chemical Distribution: Three Attractive Markets
Desirable Markets - The area of life sciences covers nutrition, health and wellness of animals and humans. As such, several segments of this industry are attractive to chemical distributors, in particular pharmaceuticals, food, and cosmetics. Chemical distributors supply these segments with ingredients, additives, excipients and processing aids. From a producer's perspective, the attractiveness of these segments is typically defined by relevant market size, growth, profitability and sustainability. more
Mark C. Griffiths Named Carbogen Amcis CEO
Switzerland-based Carbogen Amcis, a pharmaceutical process development and API manufacturing company, announced that Mark C. Griffiths has been named chief executive officer, effective immediately. more
Flow Chemistry for Hazardous Reactions
Magic Pill? - The kick to expand flow chemistry into new application areas is a hot topic in chemistry and pharma. Driven by the vision of highly efficient processing, reputable players put enormous efforts into converting existing and new processes from batch to flow. Indisputably, the flow process has a potential but is it the pill to cure all headaches?Chemistry Between Flow and Batch
Continuous processes are work horses in the production of commodities such as petro and industrial bulk chemicals. more
The EFCG is Pushing Its Agenda Forward During Complex Times
Tony Scott credits Hovione CEO Guy Villax with coining the phrase, "saints and sinners" when referring to the notoriously uneven playing field in the world of API and excipient manufacture at the launch of EFCG during CPhI in Brussels in 2004 . The European Fine Chemicals Group - better known as the EFCG - has become a household name over the last six years when it comes to pushing for better regulation of APIs and excipients. more
Expect High Performance
Active pharmaceutical ingredients (APIs) are something that anyone who has ever had a headache has come into contact with. These days, the worldwide market for APIs is being influenced by changes within the pharma industry, including more demand for patent-free drugs and an increasingly complex regulatory environment. Manufacturers from the East are also putting pressure on Western player. CHEManager Europe asked some of this year's CPhI exhibitors the following questions:more
Filtration, Simplified
Piece of Cake - When any chemical reaction is complete, a solid liquid separation procedure is usually required. This separation could be to recover a product or intermediate or remove impurities from the batch. In laboratories, Buchner filtration followed by tray or oven drying are usually the preferred options. In the larger scale pilot and process plants, filter dryers are often a common choice. The simplefilter is a simplified alternative to the more complex and costly technology of a filter dryer.The Technology more15.06.2010
Turning Point
Sharp Focus - 2010 could be a watershed year for the excipient sector in Europe as amendments to the falsified medicines directive bring excipient quality and safety considerations to the fore. As the second decade in the 21st century gets underway, it is a pivotal time for excipient suppliers and users, with greater attention being paid than ever before to the quality and safety of materials used to manufacture pharmaceuticals. more
Time For Action
The German advertising tagline "greed is good" is now outmoded as a basic principle of purchasing. A low purchase price does not mean that a product is actually inexpensive. Therefore the saying, "Those who buy cheap buy twice" often applies. As it would seem, this commonplace insight for consumer goods also applies in the chemical and pharmaceutical industries. Quality obviously does not always correlate with price. more- Legal
- Help
- Participate
- Related Publications